[et_pb_section fb_built=”1″ fullwidth=”on” _builder_version=”4.16″ _module_preset=”default” background_image=”https://healthpolicy.se/wp-content/uploads/2021/11/Ill-2-smal-kopia.png” background_position=”top_right” custom_padding=”||205px|||” global_colors_info=”{}”][/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_row _builder_version=”4.16″ _module_preset=”default” custom_padding=”||0px|||” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_text admin_label=”Title” _builder_version=”4.16″ text_font=”||||||||” header_font=”||||||||” header_line_height=”1.2em” header_2_font=”Quattrocento||||||||” header_2_font_size=”60px” header_2_line_height=”1.3em” text_orientation=”center” custom_margin=”||10px|” animation_style=”fade” animation_direction=”left” animation_starting_opacity=”100%” header_2_font_size_tablet=”40px” header_2_font_size_phone=”” header_2_font_size_last_edited=”on|desktop” inline_fonts=”Abel” global_colors_info=”{}”]

Styrelse

[/et_pb_text][/et_pb_column][/et_pb_row][et_pb_row _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_divider divider_position=”center” _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][/et_pb_divider][/et_pb_column][/et_pb_row][et_pb_row column_structure=”1_3,1_3,1_3″ _builder_version=”4.17.4″ _module_preset=”default” min_height=”331.2px” custom_padding=”||0px|||” global_colors_info=”{}”][et_pb_column type=”1_3″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_image src=”https://healthpolicy.se/wp-content/uploads/2022/06/Peter_Graf-e1655457301341.png” title_text=”Peter_Graf” _builder_version=”4.17.4″ _module_preset=”default” width=”98.1%” min_height=”252.3px” custom_padding=”|15px||||” global_colors_info=”{}”][/et_pb_image][/et_pb_column][et_pb_column type=”1_3″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_image src=”https://healthpolicy.se/wp-content/uploads/2023/06/p_Lena-Furmark_Svenskt-NC3A4ringsliv_20230309_024_PRINT.jpg” title_text=”p_Lena-Furmark_Svenskt-Nringsliv_20230309_024_PRINT” _builder_version=”4.21.0″ _module_preset=”default” global_colors_info=”{}”][/et_pb_image][/et_pb_column][et_pb_column type=”1_3″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_image src=”https://healthpolicy.se/wp-content/uploads/2022/06/maria-fagerquist-e1655456817824.jpeg” title_text=”maria-fagerquist” _builder_version=”4.17.4″ _module_preset=”default” global_colors_info=”{}”][/et_pb_image][/et_pb_column][/et_pb_row][et_pb_row column_structure=”1_3,1_3,1_3″ _builder_version=”4.17.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”1_3″ _builder_version=”4.17.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.25.1″ _module_preset=”default” hover_enabled=”0″ global_colors_info=”{}” sticky_enabled=”0″]

Peter Graf, ordförande
tidigare VD, Tiohundra

[/et_pb_text][/et_pb_column][et_pb_column type=”1_3″ _builder_version=”4.17.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.25.1″ _module_preset=”default” hover_enabled=”0″ global_colors_info=”{}” sticky_enabled=”0″]

Lena Furmark, vice ordförande
Välfärdsexpert
Svenskt Näringsliv

[/et_pb_text][/et_pb_column][et_pb_column type=”1_3″ _builder_version=”4.17.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.17.4″ _module_preset=”default” global_colors_info=”{}”]

Maria Fagerquist, ledamot
Sakkunnig policy
LIF, De forskande läkemedelsföretagen

 

[/et_pb_text][/et_pb_column][/et_pb_row][et_pb_row column_structure=”1_3,1_3,1_3″ _builder_version=”4.17.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”1_3″ _builder_version=”4.17.4″ _module_preset=”default” global_colors_info=”{}”][/et_pb_column][et_pb_column type=”1_3″ _builder_version=”4.17.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_image src=”https://healthpolicy.se/wp-content/uploads/2021/09/IngerRos-1-e1655456426130.jpg” title_text=”IngerRos-1″ _builder_version=”4.21.0″ _module_preset=”default” module_alignment=”center” global_colors_info=”{}”][/et_pb_image][/et_pb_column][et_pb_column type=”1_3″ _builder_version=”4.17.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_image src=”https://healthpolicy.se/wp-content/uploads/2023/06/Annika-Wahlin-300×366.jpg” title_text=”Annika-Wåhlin” _builder_version=”4.21.0″ _module_preset=”default” global_colors_info=”{}”][/et_pb_image][/et_pb_column][/et_pb_row][et_pb_row column_structure=”1_3,1_3,1_3″ _builder_version=”4.17.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”1_3″ _builder_version=”4.17.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.25.1″ _module_preset=”default” hover_enabled=”0″ global_colors_info=”{}” sticky_enabled=”0″]

Katarina Beech, ledamot
Public Affairs
Bristol Myers Squibb

[/et_pb_text][/et_pb_column][et_pb_column type=”1_3″ _builder_version=”4.17.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.25.1″ _module_preset=”default” hover_enabled=”0″ global_colors_info=”{}” sticky_enabled=”0″]

Inger Ros, ledamot
Patientföreträdare
Riksförbundet HjärtLung

[/et_pb_text][/et_pb_column][et_pb_column type=”1_3″ _builder_version=”4.17.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.25.1″ _module_preset=”default” hover_enabled=”0″ global_colors_info=”{}” sticky_enabled=”0″]

Annika Wåhlin, ledamot
Vårdstrateg
Vårdförbundet

[/et_pb_text][/et_pb_column][/et_pb_row][et_pb_row column_structure=”1_2,1_2″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”1_2″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”]

Möt Peter Graf, ordförande för Forum för Health Policy 

Vad är Forum för Health Policy? Varför är det så viktigt?
Här berättar Peter Graf om Forum för Health Policy. 

Följ oss på:

Facebook @forumforhealthpolicy

Instagram @forumforhealthpolicy

Twitter @FfHealthPolicy

LinkedIn @Forum för Health Policy

[/et_pb_text][/et_pb_column][et_pb_column type=”1_2″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_code _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][/et_pb_code][/et_pb_column][/et_pb_row][et_pb_row _builder_version=”4.17.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.17.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_divider _builder_version=”4.17.4″ _module_preset=”default” global_colors_info=”{}”][/et_pb_divider][/et_pb_column][/et_pb_row][et_pb_row _builder_version=”4.17.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.17.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.17.4″ _module_preset=”default” global_colors_info=”{}”]

Stadgar

Forum för Health Policys stadgar >>>

[/et_pb_text][/et_pb_column][/et_pb_row][/et_pb_section]